Tag: Amlitelimab
Sanofi announces phase II results for Amlitelimab – 03/11/2024 at 07:08
Sanofi SA SASY.PA: * NEW PHASE II RESULTS RELATING TO AMLITELIMAB CONFIRM ITS POTENTIAL AS BEST-IN-CLASS DRUG IN TERMS OF MAINTAINING RESPONSE IN THE TREATMENT OF ATOPIC DERMATITIS *BREAKING DATA…